HALO logo
halo search icon
JNJ
Johnson & Johnson

JNJ · Johnson & Johnson

249.94

USD
1.12 (0.448%)
21/07/2026 10:36:13 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$598.96B

PE

18.80

EV/EBITDA

15.8

DIV Yield

2.5%

Payout Ratio

47%

MQV Rating

2Strong

As at 21/07/2026 10:36:13 AM

Price Chart

Description

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

  • All-Companies
  • All-Consensus
  • HALO 200
  • HALO 50
  • HALO 500
  • HALO All
  • HALO Capital Efficiency
  • Hammer Bullish (Realtime)

Key Fundamentals

EPS 3 yr Growth

62.90%

EBITDA Margin

35.70%

Operating Cashflow

$24,530m

Free Cash Flow Return

21.70%

ROIC

23.70%

Interest Coverage

22.60

Quick Ratio

0.80

Performance

52 weeks range

Low 162.78 - 269.43

Trade Value (12mth)

US$450,484,568.00

1 week

-1.53%

1 month

8.04%

YTD

22.04%

1 year

54.58%

All time high

269.43

Additional Data

Shares Outstanding (Fully Diluted)

2,743m

HALO Sector

Healthcare

Next Company Report Date

26-Jan-27

Next Ex Dividend Date

25-Aug-26

Next Dividend Pay Date

08-Sep-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Strong

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
15 July 26EDG
26 June 26EDG
26 June 26EDG
26 June 26EDG
26 June 26EDG

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Johnson & Johnson (JNJ:NYS)?
Halo FAQ
The current share price of Johnson & Johnson (JNJ:NYS) is USD$249.94.
2
What is the 52-week high share price for Johnson & Johnson (JNJ:NYS)?
Halo FAQ
The 52-week high share price for Johnson & Johnson (JNJ:NYS) is USD$269.43.
3
What is the 52-week low share price for Johnson & Johnson (JNJ:NYS)?
Halo FAQ
The 52-week low share price for Johnson & Johnson (JNJ:NYS) is USD$162.78.
4
What is the dividend yield for Johnson & Johnson (JNJ:NYS)?
Halo FAQ
The current TTM dividend payout for Johnson & Johnson (JNJ:NYS) is 2.50.
5
What was Johnson & Johnson (JNJ:NYS) last dividend payment?
Halo FAQ
The last dividend payment of Johnson & Johnson (JNJ:NYS) is USD$1.34.
6
What is the franking level for Johnson & Johnson (JNJ:NYS)?
Halo FAQ
Johnson & Johnson (JNJ:NYS) has a franking level of 0.00%.
7
In which sector is Johnson & Johnson (JNJ:NYS) classified?
Halo FAQ
Johnson & Johnson (JNJ:NYS) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Johnson & Johnson (JNJ:NYS)?
Halo FAQ
The current P/E ratio for Johnson & Johnson (JNJ:NYS) is 18.80.